EGFR L747P mutation in one lung adenocarcinoma patient responded to afatinib treatment: a case report

被引：13
|
作者：
Zhou, Tong [1 ]
Zhou, Xiaoyue [1 ]
Li, Peng [1 ]
Qi, Chuang [2 ]
Ling, Yang [1 ]
机构：
[1] Soochow Univ, Dept Med Oncol, Changzhou Canc Hosp, 68 Honghe Rd, Changzhou 213032, Peoples R China
[2] 3D Med Inc, Med Dept, Shanghai 201100, Peoples R China
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷 / 12期
关键词：
RESISTANCE; CANCER;
D O I：
10.21037/jtd.2018.12.26
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：E802 / E805
页数：4
相关论文
共 50 条
  • [41] A Novel EGFR Germline Mutation in Lung Adenocarcinoma: Case Report and Literature Review
    Sharma, Parth
    Mahadevia, Himil
    Donepudi, Sreekanth
    Kujtan, Lara
    Gustafson, Beth
    Ponvilawan, Ben
    Al-Obaidi, Ammar
    Subramanian, Janakiraman
    Bansal, Dhruv
    CLINICAL LUNG CANCER, 2024, 25 (05) : 479 - 482
  • [42] Concomitant EGFR mutation and ALK rearrangement in multifocal lung adenocarcinoma: a case report
    Jun Fan
    Junhua Wu
    Bo Huang
    Yili Zhu
    Heshui Shi
    Xiaofang Dai
    Xiu Nie
    Diagnostic Pathology, 15
  • [43] Concomitant EGFR mutation and ALK rearrangement in multifocal lung adenocarcinoma: a case report
    Fan, Jun
    Wu, Junhua
    Huang, Bo
    Zhu, Yili
    Shi, Heshui
    Dai, Xiaofang
    Nie, Xiu
    DIAGNOSTIC PATHOLOGY, 2020, 15 (01)
  • [44] Lung adenocarcinoma with EGFR gene mutation metastatic to the uterine cervix A case report
    Wang, Yong
    Chen, Lin
    Wang, Zhi
    Liu, Shubin
    MEDICINE, 2020, 99 (42) : E22636
  • [45] Long progression-free survival with afatinib in a patient with EGFR-unknown lung adenocarcinoma after erlotinib failure: a case report
    Vitale, Maria Giuseppa
    Scagliarini, Sarah
    Riccardi, Ferdinando
    Barbato, Carmela
    Otero, Manuela
    Mocerino, Carmela
    Ambrosio, Francesca
    Carteni, Giacomo
    TUMORI JOURNAL, 2015, 101 (02): : E64 - E66
  • [46] Afatinib response in a lung adenocarcinoma with novel compound S720F+L861R mutation in EGFR
    Zhang, Xiangyu
    Jiang, Wenjuan
    Yang, Nong
    Zhang, Yongchang
    LUNG CANCER, 2020, 148 : 170 - 172
  • [47] Case Report: Afatinib Sensitivity in Rare EGFR E746_L747delinsIP Mutated LUAD With Peritoneal Metastases
    Zhang, Lili
    Yang, Lu
    Sun, Binxu
    Deng, Yixiao
    Yang, Jie
    Wu, Dongfang
    Kong, Fanming
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Successful treatment with an EGFR tyrosine kinase inhibitor Afatinib in a patient with combined small-cell lung Cancer with EGFR mutation
    Tanaka, Midori
    Ishii, Hidenobu
    Moribuchi, Hayato
    Naito, Yoshiko
    Matsuo, Norikazu
    Nakamura, Masayuki
    Tokito, Takaaki
    Azuma, Koichi
    Yamada, Kazuhiko
    Hoshino, Tomoaki
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (04) : 715 - 717
  • [49] Successful treatment with an EGFR tyrosine kinase inhibitor Afatinib in a patient with combined small-cell lung Cancer with EGFR mutation
    Midori Tanaka
    Hidenobu Ishii
    Hayato Moribuchi
    Yoshiko Naito
    Norikazu Matsuo
    Masayuki Nakamura
    Takaaki Tokito
    Koichi Azuma
    Kazuhiko Yamada
    Tomoaki Hoshino
    Investigational New Drugs, 2018, 36 : 715 - 717
  • [50] A Rare Presentation of a Non-Asian Female With Metastatic Non-small-cell Lung Cancer Harboring EGFR L747P Mutation With Clinical Response to Multi-targeted Epigenetic and EGFR Inhibition
    Messeha, Samia S.
    Nezami, Mohammad A.
    Hager, Steven
    Soliman, Karam F. A.
    ANTICANCER RESEARCH, 2022, 42 (01) : 441 - 447
12345